Reply to: “Is treatment of acne as simple as encouraging primary care physicians to prescribe more retinoids?” - 18/04/17
The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories LP. |
|
Disclosure: Dr Feldman is a speaker for Janssen Pharmaceuticals and Taro; is a consultant and speaker for Galderma, Stiefel/GlaxoSmithKline, Abbott Labs, and Leo Pharma Inc; has received grants from Galderma, Janssen Pharmaceuticals, Abbott Labs, Amgen, Stiefel/GlaxoSmithKline, Celgene, and Anacor; is a consultant for Amgen, Baxter, Caremark, Gerson Lehrman Group, Guidepoint Global, Hanall Pharmaceutical Co Ltd, Kikaku, Lilly, Merck & Co Inc, Merz Pharmaceuticals, Mylan, Novartis Pharmaceuticals, Pfizer Inc, Qurient, Suncare Research, and Xenoport; is on an advisory board for Pfizer Inc; is the founder and holds stock in Causa Research and holds stock and is majority owner in Medical Quality Enhancement Corporation; and receives royalties from UpToDate and Xlibris. Dr Hill's translational research is funded by Janssen Pharmaceuticals. Ms Pena has no conflicts of interest to declare. |
Vol 76 - N° 1
P. e39 - janvier 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?